AnaptysBio Gets $1.5M From DARPA

San Diego-based AnaptysBio announced this morning that it has received $1.5M in a contract from the Defense Advanced Research Projects Agency (DARPA). The firm said the contract covers developing antibodies that could be used by the military in antibody-based biosensors, including those that can detect bioterrorist threats. The company said the contact covers a two year period. Anaptys is backed by Alloy Ventures, Avalon Ventures, Frazier Healthcare Ventures, Novo A/S, Numenor Ventures, and WS Investments.